Eitan Rubinstein, MD
Gastroenterologist, Division of Gastroenterology, Hepatology and Nutrition; Director, Gastroenterology Inpatient Consult Service; Director, Transnasal Endoscopy Unit
Assistant Professor of Pediatrics, Harvard Medical School
Image
Eitan Rubinstein, MD
Gastroenterologist, Division of Gastroenterology, Hepatology and Nutrition; Director, Gastroenterology Inpatient Consult Service; Director, Transnasal Endoscopy Unit
Assistant Professor of Pediatrics, Harvard Medical School
Medical Services
Languages
English
Spanish
Education
Undergraduate School
University of California San Diego
1999
San Diego
CA
Medical School
University of Southern California School of Medicine
2003
Los Angeles
CA
Internship
Pediatric Primary Care
Boston Combined Residency Program (BCRP)
2004
Boston
MA
Residency
Pediatric Primary Care Track
Boston Combined Residency Program (BCRP)
2006
Boston
MA
Fellowship
Pediatric Gastroenterology, Hepatology, and Nutrition
University of California
2010
San Diego
CA
Media
Certifications
American Board of Pediatrics (Gastroenterology)
Publications
The role of dupilumab in the treatment of eosinophilic esophagitis. View Abstract
Characterization of Eosinophilic Esophagitis in Infants and Toddlers. View Abstract
Real World Experience With Dupilumab in Eosinophilic Esophagitis in Children and Young Adults at a Tertiary Care Pediatric Medical Center. View Abstract
Oral viscous mometasone is an effective treatment for eosinophilic esophagitis. View Abstract
Respiratory symptoms associated with eosinophilic esophagitis. View Abstract
Every-other-day Dosing of Oral Viscous Budesonide Is not Effective in the Management of Eosinophlic Esophagitis. View Abstract
Comparison of 2 delivery vehicles for viscous budesonide to treat eosinophilic esophagitis in children. View Abstract
Abdominal attacks and treatment in hereditary angioedema with C1-inhibitor deficiency. View Abstract
The utility of endoscopy and multichannel intraluminal impedance testing in children with cough and wheezing. View Abstract
Topical inhaled ciclesonide for treatment of eosinophilic esophagitis. View Abstract
Siglec-F inhibition reduces esophageal eosinophilia and angiogenesis in a mouse model of eosinophilic esophagitis. View Abstract
Hepatic, cardiovascular, and endocrine outcomes of the histological subphenotypes of nonalcoholic fatty liver disease. View Abstract